The price of a CJC-1295 and ipamorelin program is mostly the clinical wrapper, not the peptide. Baseline labs, a prescribing physician, and 503A or 503B compounding are what separate a legitimate monthly cost from a research-chemical vial.
A CJC-1295 and ipamorelin stack through legitimate telehealth runs in the range of roughly $150 to $400 per month, and the exact figure varies by provider, dose, and what the program bundles. The peptide itself is a small part of that. Most of the cost is the clinical wrapper: a prescribing physician, baseline and follow-up labs, and compounding at a licensed 503A or 503B pharmacy. Programs advertising a fraction of that price are usually selling something different from what a clinic dispenses.
- A legitimate CJC-1295 and ipamorelin stack runs roughly $150 to $400 per month and varies by provider and dose.
- Most of the cost is the clinical wrapper: physician, labs, and 503A or 503B compounding, not the peptide.
- Research-chemical vials are cheaper because they omit the prescription, labs, and verified compounding.
- The FDA flags both peptides as bulk substances with compounding safety concerns; WADA bans them in sport.
- Pricing hidden behind a sales call and no required baseline labs are consistent red flags.
What Actually Drives the Price
Four things set the monthly cost, and only one of them is the peptide.
- Compounding pharmacy: a 503A patient-specific pharmacy or a 503B outsourcing facility. 503B is the higher regulatory standard and generally costs more.
- Physician oversight: the consultation and prescription are a real medical service, not a formality.
- Lab work: a baseline IGF-1 before prescribing and a 90-day retest, sometimes bundled, sometimes billed separately.
- Dose and schedule: CJC-1295 with DAC is dosed about weekly on its 6 to 8 day half-life [1]; the no-DAC version and ipamorelin, a selective GH secretagogue, are dosed more often, which changes how fast a vial is used [2].
What a Legitimate Program Includes
A real telehealth peptide program is priced as a bundle, and the bundle is where the value sits. Before it prescribes, it draws a baseline IGF-1, because that confirms the GH axis is low and gives a number to measure against [3]. It formulates CJC-1295 and ipamorelin at a licensed pharmacy with a Certificate of Analysis. It includes physician follow-up and a 90-day retest. The monthly figure covers all of that, not a vial in isolation.
- A baseline IGF-1 before the first prescription
- CJC-1295 and ipamorelin compounded at a 503A or 503B pharmacy with a Certificate of Analysis
- A prescribing physician and documented follow-up
- A 90-day IGF-1 retest to confirm response and guide the dose
Why the Cheap Research-Chemical Vials Cost More in the End
Peptides sold as research chemicals list a low price because they leave out everything that makes the treatment safe. These vials carry a not-for-human-use label, come with no prescription, no physician, and no baseline labs, and their contents are not verified. The FDA lists CJC-1295 and ipamorelin among bulk substances flagged for compounding safety concerns [4]. A lower number on a gray-market vial is not the same product as a prescribed, pharmacy-compounded protocol.
Red Flags in a Peptide Price
The price structure itself tells you whether a program is legitimate.
- No baseline labs required before purchase. Skipping IGF-1 is a red flag regardless of price.
- Pricing shown only after a sales call. Legitimate programs publish what the protocol costs.
- No named prescribing physician or disclosed pharmacy type.
- Vials labeled research use only or not for human consumption.
- A monthly price far below the market range, which usually means no labs, no physician, or unverified compounding.
Is It a Controlled or Banned Substance?
CJC-1295 and ipamorelin are not FDA-approved drugs; they are compounded peptides, and neither is FDA-approved for anti-aging or body composition. Both are on the World Anti-Doping Agency prohibited list as growth hormone-releasing factors, so any competing athlete is barred from using them [5]. That status does not make a prescribed protocol illegal for a general patient, but it does mean the peptides sit outside the approved-drug system, which is why the pharmacy and physician wrapper matters [4].
A CJC-1295 and ipamorelin price only means something if it includes a baseline IGF-1, a prescribing physician, and licensed compounding. SystemLabs tests IGF-1 before prescribing and formulates the stack at a licensed pharmacy on clinical indication, so the monthly cost buys a monitored protocol rather than an unverified vial.
Bottom Line
Frequently Asked Questions
How much does a CJC-1295 and ipamorelin stack cost per month?
Through legitimate telehealth, a CJC-1295 and ipamorelin stack generally runs in the range of $150 to $400 per month. The exact price varies by provider, dose, and whether labs and physician follow-up are bundled. Most of that cost is the clinical program around the peptide, not the peptide itself.
Why is CJC-1295 ipamorelin cheaper from research-chemical sites?
Research-chemical vials are cheaper because they leave out the prescription, the prescribing physician, the baseline IGF-1 labs, and verified pharmacy compounding. They are labeled not for human use and their contents are not confirmed. The lower price reflects a different, unregulated product, not a discount on the same protocol.
What should a legitimate peptide program include for the price?
A legitimate program includes a baseline IGF-1 before prescribing, CJC-1295 and ipamorelin compounded at a licensed 503A or 503B pharmacy with a Certificate of Analysis, a prescribing physician, and a 90-day IGF-1 retest. If the price does not include labs and physician oversight, it is not a complete program.
Does the dosing schedule change the cost?
Yes. CJC-1295 with DAC has a 6 to 8 day half-life and is dosed about weekly, while the no-DAC version and ipamorelin are dosed more frequently. More frequent dosing uses a vial faster, which affects the monthly cost. The compounding pharmacy type and the included labs move the price more than the schedule alone.
Are CJC-1295 and ipamorelin legal to buy?
CJC-1295 and ipamorelin are compounded peptides, not FDA-approved drugs, and they are prescribed through licensed telehealth by a physician. They are not approved for anti-aging or body composition, and both are on the World Anti-Doping Agency prohibited list, so athletes in tested sport cannot use them. Buying them without a prescription from a research-chemical source falls outside that regulated pathway.
References
- Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog Endocrinology, 2005. PMID: 15817669. https://pubmed.ncbi.nlm.nih.gov/15817669/
- Ipamorelin, the first selective growth hormone secretagogue European Journal of Endocrinology, 1998. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women Journal of Clinical Endocrinology & Metabolism, 1997. PMID: 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Certain bulk drug substances for use in compounding that may present significant safety risks FDA.gov, Human Drug Compounding, 2026. FDA Category 2 bulk substances list. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- The 2026 Prohibited List: International Standard, section S2.2.4 growth hormone releasing factors World Anti-Doping Agency, 2026. WADA 2026 Prohibited List. https://www.wada-ama.org/en/resources/2026-prohibited-list
